CLINICAL_TRIALS
trial_result
· 2025-04-24
Clinical Trial Update: A Study of AK0529 in Adults Patients Hospitalized With RSV Infection [Phase 2]
Summary
A Phase 2 clinical trial evaluating AK0529 in adults hospitalized with respiratory syncytial virus infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED